Follow
Christopher E Shaw
Christopher E Shaw
Institute of Psychiatry, King's College London
Verified email at kcl.ac.uk
Title
Cited by
Cited by
Year
The ATLAS simulation infrastructure
G Aad, B Abbott, J Abdallah, AA Abdelalim, A Abdesselam, B Abi, ...
The European Physical Journal C 70 (3), 823-874, 2010
70482010
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ...
Nature genetics 41 (10), 1088-1093, 2009
30112009
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
J Sreedharan, IP Blair, VB Tripathi, X Hu, C Vance, B Rogelj, S Ackerley, ...
Science 319 (5870), 1668-1672, 2008
26952008
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6
C Vance, B Rogelj, T Hortobágyi, KJ De Vos, AL Nishimura, J Sreedharan, ...
Science 323 (5918), 1208-1211, 2009
26872009
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ...
Nature genetics 43 (5), 429-435, 2011
19402011
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
14292019
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS
HJ Kim, NC Kim, YD Wang, EA Scarborough, J Moore, Z Diaz, ...
Nature 495 (7442), 467-473, 2013
13242013
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
D Lambrechts, E Storkebaum, M Morimoto, J Del-Favero, F Desmet, ...
Nature genetics 34 (4), 383-394, 2003
10742003
Characterizing the RNA targets and position-dependent splicing regulation by TDP-43
JR Tollervey, T Curk, B Rogelj, M Briese, M Cereda, M Kayikci, J König, ...
Nature neuroscience 14 (4), 452-458, 2011
10462011
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
ET Cirulli, BN Lasseigne, S Petrovski, PC Sapp, PA Dion, CS Leblond, ...
Science 347 (6229), 1436-1441, 2015
8682015
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
MR Turner, A Cagnin, FE Turkheimer, CCJ Miller, CE Shaw, DJ Brooks, ...
Neurobiology of disease 15 (3), 601-609, 2004
7642004
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
7312017
Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations
NH Alami, RB Smith, MA Carrasco, LA Williams, CS Winborn, SSW Han, ...
Neuron 81 (3), 536-543, 2014
5842014
Proteome-based plasma biomarkers for Alzheimer's disease
A Hye, S Lynham, M Thambisetty, M Causevic, J Campbell, HL Byers, ...
Brain 129 (11), 3042-3050, 2006
5452006
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2
MC Moreira, S Klur, M Watanabe, AH Németh, IL Ber, JC Moniz, ...
Nature genetics 36 (3), 225-227, 2004
5192004
p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS
S Al-Sarraj, A King, C Troakes, B Smith, S Maekawa, I Bodi, B Rogelj, ...
Acta neuropathologica 122 (6), 691-702, 2011
5112011
Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis
NJ Rutherford, YJ Zhang, M Baker, JM Gass, NCA Finch, YF Xu, ...
PLoS genetics 4 (9), e1000193, 2008
4972008
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ...
Nature genetics 48 (9), 1043-1048, 2016
4852016
ER–mitochondria associations are regulated by the VAPB–PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43
R Stoica, KJ De Vos, S Paillusson, S Mueller, RM Sancho, KF Lau, ...
Nature communications 5 (1), 1-12, 2014
4802014
Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic
YB Lee, HJ Chen, JN Peres, J Gomez-Deza, J Attig, M Štalekar, ...
Cell reports 5 (5), 1178-1186, 2013
4782013
The system can't perform the operation now. Try again later.
Articles 1–20